These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34975614)

  • 1. An Encounter With the Other: A Thematic and Content Analysis of DMT Experiences From a Naturalistic Field Study.
    Michael P; Luke D; Robinson O
    Front Psychol; 2021; 12():720717. PubMed ID: 34975614
    [No Abstract]   [Full Text] [Related]  

  • 2. An encounter with the self: A thematic and content analysis of the DMT experience from a naturalistic field study.
    Michael P; Luke D; Robinson O
    Front Psychol; 2023; 14():1083356. PubMed ID: 37051610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience.
    Lawrence DW; Carhart-Harris R; Griffiths R; Timmermann C
    Sci Rep; 2022 May; 12(1):8562. PubMed ID: 35610230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. This is your brain on death: a comparative analysis of a near-death experience and subsequent 5-Methoxy-DMT experience.
    Michael P; Luke D; Robinson O
    Front Psychol; 2023; 14():1083361. PubMed ID: 37457069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N, N-Dimethyltryptamine (DMT)-Occasioned Familiarity and the Sense of Familiarity Questionnaire (SOF-Q).
    Lawrence DW; DiBattista AP; Timmermann C
    J Psychoactive Drugs; 2024; 56(4):443-455. PubMed ID: 37428989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DMT Models the Near-Death Experience.
    Timmermann C; Roseman L; Williams L; Erritzoe D; Martial C; Cassol H; Laureys S; Nutt D; Carhart-Harris R
    Front Psychol; 2018; 9():1424. PubMed ID: 30174629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.
    Griffiths RR; Hurwitz ES; Davis AK; Johnson MW; Jesse R
    PLoS One; 2019; 14(4):e0214377. PubMed ID: 31013281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of entity encounter experiences occasioned by inhaled
    Davis AK; Clifton JM; Weaver EG; Hurwitz ES; Johnson MW; Griffiths RR
    J Psychopharmacol; 2020 Sep; 34(9):1008-1020. PubMed ID: 32345112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience.
    Gallimore AR; Strassman RJ
    Front Pharmacol; 2016; 7():211. PubMed ID: 27471468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety.
    Davis AK; So S; Lancelotta R; Barsuglia JP; Griffiths RR
    Am J Drug Alcohol Abuse; 2019; 45(2):161-169. PubMed ID: 30822141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline Power of Theta Oscillations Predicts Mystical-Type Experiences Induced by DMT in a Natural Setting.
    Tagliazucchi E; Zamberlan F; Cavanna F; de la Fuente L; Romero C; Sanz Perl Y; Pallavicini C
    Front Psychiatry; 2021; 12():720066. PubMed ID: 34803754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of 5-methoxy- N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption.
    Davis AK; Barsuglia JP; Lancelotta R; Grant RM; Renn E
    J Psychopharmacol; 2018 Jul; 32(7):779-792. PubMed ID: 29708042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dance Movement Therapy for Clients With a Personality Disorder: A Systematic Review and Thematic Synthesis.
    Kleinlooh ST; Samaritter RA; van Rijn RM; Kuipers G; Stubbe JH
    Front Psychol; 2021; 12():581578. PubMed ID: 33868071
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying.
    Sweeney MM; Nayak S; Hurwitz ES; Mitchell LN; Swift TC; Griffiths RR
    PLoS One; 2022; 17(8):e0271926. PubMed ID: 36001643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms.
    Uthaug MV; Lancelotta R; van Oorsouw K; Kuypers KPC; Mason N; Rak J; Šuláková A; Jurok R; Maryška M; Kuchař M; Páleníček T; Riba J; Ramaekers JG
    Psychopharmacology (Berl); 2019 Sep; 236(9):2653-2666. PubMed ID: 30982127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers.
    Reckweg J; Mason NL; van Leeuwen C; Toennes SW; Terwey TH; Ramaekers JG
    Front Pharmacol; 2021; 12():760671. PubMed ID: 34912222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects.
    Lancelotta RL; Davis AK
    J Psychoactive Drugs; 2020; 52(3):273-281. PubMed ID: 32148190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study.
    Barsuglia J; Davis AK; Palmer R; Lancelotta R; Windham-Herman AM; Peterson K; Polanco M; Grant R; Griffiths RR
    Front Psychol; 2018; 9():2459. PubMed ID: 30574112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic medial parietal and hippocampal deactivations under DMT relate to sympathetic output and altered sense of time, space, and the self.
    Pasquini L; Simon AJ; Gallen CL; Kettner H; Roseman L; Gazzaley A; Carhart-Harris RL; Timmermann C
    bioRxiv; 2024 Aug; ():. PubMed ID: 38464275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.